Physician profile
Ty T Webb
NPI 1174512974
$1,586.16
in general payments reported to CMS, 2019-2025
23 companies · $15.00 in 2025
The $15.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $619 · 2022: $38.33 · 2023: $129 · 2024: $22.63 · 2025: $15.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.91 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $225.72 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $173.95 | 2019-2020 | |
| Lilly USA, LLC | $122.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $116.08 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $102.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $101.82 | 2019-2020 | |
| Amgen INC. | $98.06 | 2019-2020 | |
| Sanofi Pasteur INC. | $92.43 | 2023 | |
| Allergan, INC. | $80.42 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $72.37 | 2019 | |
| Pfizer INC. | $71.47 | 2019-2020 | |
| Abbvie INC. | $52.58 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $48.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.86 | 2019-2020 | |
| Astellas Pharma US INC | $38.81 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $27.34 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $22.63 | 2024 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Amarin Pharma, INC. | $18.47 | 2020 | |
| Medtronic, INC. | $15.00 | 2025 | Minimed 780g |
| Mylan Specialty L.P. | $14.80 | 2020 | |
| Glaxosmithkline, LLC. | $11.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ty Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.